Expert agreement with assumptions about tumor growth, disease progression and survival in patients with NSCLC, after the second survey round. Responses of “Agree” and “Strongly Agree” were combined, as were responses of “Disagree” and “Strongly Disagree.” One expert did not provide a response to the final assumption
NSCLC – Non-small cell lung cancer
TVDT – Tumor volume doubling time